OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis
Michael E. Wechsler, Parameswaran Nair, Benjamin Terrier, et al.
New England Journal of Medicine (2024) Vol. 390, Iss. 10, pp. 911-921
Closed Access | Times Cited: 41

Showing 26-50 of 41 citing articles:

Benralizumab noninferior to mepolizumab for EGPA
Sarah Onuora
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 5, pp. 253-253
Closed Access

La granulomatose éosinophile avec polyangéite
Jean-Marie Manus
Revue Francophone des Laboratoires (2024) Vol. 2024, Iss. 562, pp. 13-13
Closed Access

Update on antineutrophil cytoplasmic autoantibody vasculitis in children
Jessica L. Bloom, Eveline Y. Wu
Current Opinion in Rheumatology (2024) Vol. 36, Iss. 5, pp. 336-343
Closed Access

Head-to-Head-Studien bei Kollagenosen und Vaskulitiden
Bernhard Hellmich, Johanna Mücke, Martin Aringer
Zeitschrift für Rheumatologie (2024) Vol. 83, Iss. 8, pp. 620-628
Closed Access

Severe Eosinophilic Asthma or Eosinophilic Granulomatosis with Polyangitis: potential biomarkers for novel diagnostic strategies.
Manuela Latorre, Veronica Seccia, Ilaria Puxeddu, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 11, pp. 3057-3067
Closed Access

Biologics in Hypereosinophilic Syndrome and Eosinophilic Granulomatosis with Polyangiitis
Ejiofor A.D. Ezekwe, Andrew L. Weskamp, Luke Pittman, et al.
Immunology and Allergy Clinics of North America (2024) Vol. 44, Iss. 4, pp. 629-644
Closed Access

Therapie-Update der ANCA-assoziierten Vaskulitiden
Julia U. Holle, Frank Moosig
Zeitschrift für Rheumatologie (2024) Vol. 83, Iss. 10, pp. 787-799
Closed Access

Long-term efficacy of mepolizumab on eosinophilic granulomatosis with polyangiitis: a retrospective study
Takahiro Matsuyama, Hiromi Matsuyama, Yoichi Dotake, et al.
(2024) Vol. 2, Iss. 6, pp. 461-472
Closed Access

Dupilumab for refractory chronic rhinosinusitis in eosinophilic granulomatosis with polyangiitis
Roberto Padoan, F. Davanzo, Luca Iorio, et al.
Lara D. Veeken (2024)
Closed Access

Characteristics of Severe Asthma Clinic Patients with Eosinophilic Granulomatosis with Polyangiitis
You Xin Puan, Kheng Yong Ong, Pei Yee Tiew, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024)
Open Access

Steroid-sparing strategy for the treatment of vasculitis associated with antineutrophil cytoplasmic antibodies
О. Н. Егорова, Г. М. Тарасова, A. V. Datsina, et al.
Modern Rheumatology Journal (2024) Vol. 18, Iss. 5, pp. 107-115
Open Access

Ten clinical conundrums in the management of eosinophilic granulomatosis with polyangiitis
Íñigo Rúa‐Figueroa, Roser Soláns-Laqué, Marina Blanco–Aparicio, et al.
Expert Review of Clinical Immunology (2024), pp. 1-15
Closed Access

Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factors
Boris Sorin, Matthias Papo, Renato Alberto Sinico, et al.
Journal of Autoimmunity (2024) Vol. 149, pp. 103338-103338
Closed Access

Quoi de neuf en médecine interne et immunologie clinique ?
P. Cacoub
Annales de Dermatologie et de Vénéréologie - FMC (2024) Vol. 4, Iss. 8, pp. 8S21-8S26
Closed Access

Precision medicine and choosing a biologic in asthma: understanding the current state of knowledge for predictors of response and clinical remission
Sadhana Balasubramanyam, Elizabeth George, Eileen Wang
Current Opinion in Allergy and Clinical Immunology (2024) Vol. 25, Iss. 1, pp. 66-74
Closed Access

Benralizumab: from tissue distribution to eosinophilic cytotoxicity up to potential immunoregulation
Alessandra Vultaggio, Laura Bergantini, Claudia Crimi, et al.
Expert Opinion on Biological Therapy (2024), pp. 1-11
Closed Access

Vasculites associadas aos anticorpos anticitoplasma de neutrófilos (ANCA): granulomatose eosinofílica com poliangiite
Carolina Tiemi Tonholo Ikedo, Chélida de Souza Dutra, João Gabriel Dantas, et al.
Revista Paulista de Reumatologia (2024) Vol. 23, Iss. 2, pp. 21-29
Closed Access

Previous Page - Page 2

Scroll to top